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The bioavailability of volatile organic compounds (VOCs) in a given situation often remains 
challenging to assess, and the lack of standard methods for introducing VOCs into in vitro 
bioassays can lead to poorly defined bioavailable concentrations. As a result, in vitro assays 
normally conducted in wells of cell culture plates for risk assessment of volatile and hydrophobic 
organic chemicals (VHOCs) have always faced significant experimental difficulties due to high 
volatility and high hydrophobicity. This compromises the true exposure concentration by: (i) 
causing the amount of test substances in the test medium to decline, (ii) limits the quality of 
toxicological responses and their extrapolation, and thus, can lead to interpretational errors. In the 
research herein, a dosing method was developed to assess the bioavailability of benzene (that 
served as a model for VHOCs) in aqueous tests and to better characterize exposure estimates for 
an improved risk assessment during in vitro biotests. This study hypothesizes that (1) benzene 
bioavailability to intestinal porcine enterocyte cell line (IPEC-1 cells) can be partially explained 
by phase partitioning, as measured by freely dissolved concentration that drives the diffusive 
uptake into the cell membranes, (2) benzene equilibrium partitioning between the donor and the 
cell membranes is dependent upon energetic state of the chemical concentration in the partitioning 
donor, which describes its chemical activity. Silicone polydimethylsiloxane (PDMS) was used as 
the partitioning donor for passive dosing in transwell plates. The buffering capacity of the donor 
compensates for routine loss against depletion processes during the toxicity tests, resulting in 
stable exposure concentrations of benzene freely available to cells at relatively constant chemical 
activity. For IPEC-1 cells in the passive dosing tests, the median effective concentration (EC50) 
was 4.82 mg/L. The obtained median effective activity (Ea50) value is within the chemical activity 
range (0.01– 0.1) for baseline toxicity of several hydrophobic chemicals reported in the literature. 
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Cell inhibition ranged from 9.6 ± 2% to 97.7 ± 0.8% for freely dissolved concentrations of benzene, 
which ranged from 0.6 to 5.4 mg/L after 24 h exposure. The spiking tests result in an ECSpike-50 
projected to be greater than 5.4 mg/L, (highest spiked concentration) and reduced test sensitivity 
of benzene to IPEC-1 cells. This study introduces a new effective approach to passive dosing and 
demonstrates the utility of passive dosing over solvent spiking for in vitro toxicity testing of 
hydrophobic chemical (log Kow ˂ 4.6) with high volatility. This has fundamental implications for 
a better understanding of the interactions between VHOCs exposure to humans and the toxic 
effects on the human intestine to help set remediation objectives and further the improve future 
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1     INTRODUCTION 
 
Benzene is a carcinogen and a widespread contaminant of groundwater. The human health risk 
associated with benzene exposure has been increasingly recognized (Boelsterli, 2003; Martínez-
Velázquez et al., 2006). For pollutants, such as benzene, to be accessible to humans, it must be 
bioavailable and cross barrier membranes to enter the systemic circulation. Environmental risk 
assessors often suggest that all of the ingested pollutants reach the site of toxic action following 
the assumption the pollutant has the same bioavailability as what occurred in the reference study. 
This notion is widely held as a conservative estimate. However, the bioavailability of orally 
ingested hydrocarbons is commonly known to vary depending on the type of hydrocarbons, dose, 
carrier (vehicle), and host-species. Hence, the question of how bioavailable of a hydrophobic 
organic chemical is in a given situation often remains difficult to answer. For volatile hydrophobic 
chemicals such as benzene, it is technically challenging to determine true exposure concentration 
and maintain constant recharge of exposure concentrations during in vitro toxicity tests. The 
research of this Master thesis introduces a new approach to passive dosing for an improved in vitro 
exposure and quantitative assessment of potential health risk from chemicals with high volatility 
and high hydrophobicity. The passive dosing model uses a silicone PDMS loaded with the test 
substance to establish a partition-controlled delivery of test concentrations, and thus provides 
direct contact with the test medium and constant exposure level at maximum chemical activity to 
epithelial cells.  
1.1 Objectives and Hypotheses 
The overall objective of this master's research is to develop a dosing system to assess benzene 
bioavailability to gastrointestinal (GI) epithelial cells and to estimate benzene transfer across the 
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cell lines. Two hypotheses are evaluated for the overall objective stated above: (1) benzene 
bioavailability to intestinal porcine enterocyte cell line (IPEC-1 cells) can be partially explained 
by phase partitioning, as measured by freely dissolved concentration that drives the diffusive 
uptake into the cell membranes, (2) benzene equilibrium partitioning between the donor and the 
cell membranes is dependent upon energetic state of the chemical concentration in the partitioning 
donor, which describes its chemical activity. 
For the two hypotheses, the freely dissolved bioavailable fractions of benzene in aqueous tests 
are determined, and their toxicity is linked to calculated chemical activity for the concentration 
exerting the toxic effect. This is presented in Chapter 3 (Development of a dosing system to assess 



















2     LITERATURE REVIEW 
2.1 Benzene  
Benzene is the simplest aromatic hydrocarbon, an important element of environmental pollution 
and occurs in crude oil and gasoline (IRIS report, 2002; Boelsterli, 2003; Burbacher, 1993). 
Benzene is produced largely in the chemical industry and also a widely used industrial product as 
an intermediate in chemical syntheses and the manufacture of products like resins, dyes, plastics, 
etc. (IRIS report, 2002; McHale et al., 2012). Benzene contamination is commonly associated with 
various industrial operations such as petroleum production, distribution processing and storage. It 
has a long history for its carcinogenic potential, most evidently from human epidemiologic studies 
and animal data (Boelsterli, 2003). Toxicokinetic studies both in humans and in animal models 
indicate that benzene, due to its lipophilicity, is readily absorbed, distributed to several highly 
vascular tissues such as bone marrow and adipose tissue, and are eliminated most rapidly from the 
body (IRIS report, 2002; U.S report, 2004). 
For benzene to become toxic, benzene must be biotransformed to reactive metabolites or 
intermediates (Boelsterli, 2003). Several benzene metabolites have been linked to benzene toxicity 
(IRIS report, 2002). The interactions of benzene metabolism and toxicity allow the prediction of 
toxic effects and can be assessed at a quantitative level only when the mode of action is understood 
(IRIS report, 2002). Benzene exposure is associated with multiple adverse health effects by all 
routes of administration (IRIS report, 2002; Burbacher 1993). The toxic effect most frequently 
observed after chronic exposure in human and animal models is the bone marrow toxicity 
(Boelsterli, 2003).  Benzene has been consistently reported to produce neurotoxic effects in test 
animals and humans after exposure in a dose-dependent manner (IRIS report, 2002). It was shown 
to induce nephrotoxicity in the kidney (Boelsterli, 2003). Acute exposure to benzene has been 
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reported to cause long-lasting changes in motor behavior and cognitive process during gestational 
organogenesis (Burbacher, 1993). Benzene has also been shown to induce hematotoxicity in 
human over decades and reports from recent studies have confirmed hematological effect at 
varying levels of benzene exposure, including those that are below the USA Occupational Safety 
and Health Administration’s permissible exposure limit of 1 part per million (ppm) in air (McHale 
et al., 2012).   
Benzene is a contaminant of potential concern, and thus, is currently regulated federally, by 
provinces and territories. In Canada, contaminants of potential concern (COPCs) are regulated to 
provide a substantial margin of safety between the Canadian Council of Ministers of the 
Environment (CCME) permissible exposure levels and the levels potentially expected to result in 
adverse toxic effects in humans, by comparing the maximum measured on-site concentration to 
CCME Environmental Quality Guidelines for protection of human health (Health Canada, 2012). 
Depending on the route of exposure, chemicals in groundwater are regulated through the 
application of Health Canada Guidelines for Canadian Drinking Water Quality. Also, many 
provinces and territories have adopted the CCME Canada-Wide Standard (CWS) for Petroleum 
Hydrocarbons (PHCs) in Soil for risk assessment at various contaminated sites (Health Canada, 
2012). In the United States, regulation for COPCs applies through the US Environmental 
Protection Agency, (US EPA) preliminary remediation goals (US EPA, 2004a) or risk-based 
concentrations (US FDA, 2006). 
2.1.1 Benzene Interaction with Toluene, Ethylbenzene, and Xylenes – (BTEX), and 
Arsenic 
Benzene contaminations frequently occurs as a joint mixture with toluene, ethylbenzene, and 
xylenes termed (BTEX). BTEX are volatile organic compounds and exhibit good solvent 
properties (U.S report, 2004). The joint toxic action of the mixture is dose-dependent based 
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metabolism that involves the cytochrome P-450 super family (CYP2E1). Exposure to BTEX is 
reported to produce neurological impairment, and further exposure to benzene reportedly causing 
hematological effects via the action of reactive metabolites. Though the carcinogenic potential of 
benzene is well established in the literatures, recent assessment by IARC (2000) have also 
suggested that ethylbenzene is possibly carcinogenic to humans, excluding toluene and xylenes 
that have been classified, by both EPA (IRIS, 2001) and IARC (1999a), as non-carcinogenic to 
humans (U.S report, 2004). Benzene's potential risk from interaction with potent toxicants such as 
arsenic (As) is also significant due to the carcinogenic potential of As. Arsenic is widely found in 
contaminated soil and groundwater, and a critical determinant of its toxic effects is the metabolism 
of trivalent inorganic arsenic, catalyzed by arsenic (+3 oxidation state) methyltransferase (As3mt), 
(Hughes et al., 2011). Comparisons between Health Canada and U.S. EPA classification on human 
toxicity reference values (TRVs) for BTEX, and Arsenic are presented in Table 2.1. The allowable 
concentrations of BTEX and Arsenic in surface water for generic uses: drinking water, aquatic 
life, and livestock based on Alberta Tier 1 Surface water quality guidelines are presented in Table 
2.2. For residential/parkland water uses, the allowable chemical concentrations are reported in 
Table 2.3. Table 2.4 shows all exposure pathways for industrial land use and the permissible 









Table 2.1   Human toxicity reference values (TRVs) for Benzene, Toluene, Ethylbenzene, and 
Xylene (BTEX), and Arsenic – Health Canada and U.S. EPA 
Non-Carcinogenic TRVs * Carcinogenic TRVs * 








US EPA Health 
Canada 
US EPA Health 
Canada 
US EPA Health 
Canada 
US EPA 








3.0 x 10-2  
 
8.3 x 10-2 
 
5.5 x 10-2  
 
1.4 x 10-2 
 
2.7 x 10-2 
Toluene  
2.2 x 10-1 
 













Ethylbenzene   
1.0 x 10-1 
 
















2.0 x 10-1 
 
1.8 x 10-1 
 



























ND – no data 
TDI – tolerable daily intake 
TC – tolerable concentration 
US EPA – United States Environmental Protection Agency 
 * U.S. EPA Interaction profile for BTEX report, 2004 and guidance document on Federal 
Contaminated Site Risk Assessment in Canada, Part II, (2010). 
 
 
Table 2.2   Alberta Tier 1 Surface water quality guidelines for generic uses of surface water and 
the allowable concentrations of (BTEX) and Arsenic in groundwater or surface water use 








Benzene 0.005 0.04 0.088 0.08 
Toluene 0.024 0.005 4.91 4.46 
Ethylbenzene 0.0016 0.09 3.20 2.91 
Xylenes 0.02 0.03 13.1 11.9 
Arsenic 
(inorganic) 
0.01 0.005 0.025 ND 
DTED – daily threshold effect dose (mg/kg-bw/d) 
ND – no data 












Potable Inhalation Aquatic life 
Unit mg/L * mg/L * mg/L * mg/L * 
Benzene 0.005 0.005 2.8 3.6 
Toluene 0.024 0.024 NGR 12,000 
Ethylbenzene 0.0016 0.0016 NGR NGR 
Xylenes 0.02 0.02 80 NGR 
Arsenic 
(inorganic) 
0.005 0.01 NGR 0.005 
NGR – no guideline required 




Table 2.4   Alberta Tier 1 Subsoil remediation guidelines for industrial land use – All exposure 
Pathways 
NGR – no guideline required 
ND – no data 









                                Human Ecological 












Unit mg/kg * mg/kg * mg/kg * mg/kg * mg/kg * mg/kg * 
Benzene 0.046 120 11 0.046 1,100 7.9 
Toluene 0.52 11,000 14,000 0.52 9,200 63,00 
Ethylbenzene 0.073 24,000 6,700 0.073 24,000 NGR 
Xylenes 0.99 8,100 1,800 0.99 6,900 NGR 
Arsenic (inorganic) ND ND ND ND ND ND 
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2.1.2 Review of Benzene Epidemiological Studies 
Toxicological parameters such as the tolerable daily intake (TDI), maximum acceptable 
concentrations (MAC), reference dose (RfD), and a number of other human health toxicity 
benchmarks are derivatives for the quantitative estimation of the threshold dose or exposure level 
that is free of detrimental effects to humans. Several case reports of adverse effect of death from 
acute oral exposure to benzene are documented in the literatures. Thienes and Haley (1972) and 
ATSDR (2007) estimate lethal oral doses of benzene in humans to be at approximately 125 mg/kg 
(125 ppm). Toxic responses such as the central nervous system depression, respiratory arrest, or 
cardiac collapse result at lethal doses to humans (Green- burg, 1926). 
Benzene exposure occurs predominantly via inhalation, and this route of exposure is what has 
been used to set toxicological reference values (IRIS report, 2002). The principal study selected 
by the U.S. EPA for the derivation of the inhalation reference concentration (RfC) and oral 
reference dose (RfD) is the human occupational epidemiological study by Rothman et al. (1996a) 
(IRIS report, 2002, IRIS report, 2003). A cross-sectional study of 44 workers exposed to benzene 
at varying concentrations and 44 other people: age-and gender-matched unexposed controls, all 
from China, were conducted. Of the 44 subjects in the exposed and control groups, twenty-one 
were female. In the study, benzene exposure was monitored for a full workshift on 5 days in a 1-2 
week period before blood sampling from the exposed subjects. Benzene exposure of control groups 
was monitored for 1 day. Six haematological parameters: absolute lymphocyte (ALC) count, total 
white blood cell (WBC) count, red blood cell count (RBCC), platelet count, hematocrit, and mean 
corpuscular volume (MCV) were evaluated in the study, and of all, reduced ALC was selected as 
the critical endpoint for the derivation of the RfC/RfD. 
9 
 
Rothman et al. (1996a) epidemiological study provides the lowest-observed-adverse-effect 
levels (LOAELs) suitable for the benchmark dose (BMD) modeling of ALC to derive a point of 
departure (POD) for the calculation of the RfC. The BMD modelling of the ALC from Rothman 
et al. (1996a) exposure-response data yielded a benchmark concentration (BMC) and a 95% lower 
bound on the BMC (BMCL) of 8.2 mg/m3, and was performed using the U.S. EPA’s BMD 
modelling software (version 1.2). The RfC is then obtained by dividing the adjusted BMCL by the 
overall uncertainty factor (UF) of 300: BMCLADJ/UF = 8.2 mg/m
3 ÷ 300 = 3 x 10-2 mg/m3. As 
most commonly used in risk assessment, the UF or safety factor is considered a safety margin that 
accounts for individual differences in sensitivity to chemical exposure. Depending on the degree 
of uncertainty, a 10-fold UF is usually used but can also assume a range of other values. 
The RfD derivation is based on route-to-route extrapolation of benzene inhalation results to oral 
exposures. The RfD is obtained by dividing the equivalent oral dose rate value calculated using 
the BMCLADJ by the overall uncertainty factor (UF) of 300: RfD = equivalent oral dose ÷ UF = 
1.2 mg/kg/day ÷ 300 = 4 × 10-3 mg/kg/day. The equivalent oral dose rate value is obtained when 
the BMCLADJ is multiplied by the default inhalation rate, multiplied by 0.5 to correct for the higher 
oral absorption, and divided by the standard default human body weight of 70 kg (U.S. EPA, 1988): 
8.2 mg/m3 × 20 m3/day × 0.5 ÷ 70 kg = 1.2 mg/kg/day.    
The Health Canada guidance on human toxicity reference value for benzene had been 
developed based on a 2-year cancer study (experimental animal gavage study) in rats and mice by 
the National Toxicological Program (NTP, 1986). Health Canada guideline for benzene is 
developed based on cancer endpoints, and this guideline provides a substantial margin of safety 
between cancer and non-cancer endpoints. The approach for quantitative estimation of cancer risks 
from exposure to benzene in the gavage study, and because carcinogenicity is considered to be the 
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critical health effects among varying adverse outcomes from benzene exposure, were deemed 
sufficient by Health Canada to serve as the basis upon which the Guidelines for Canadian Drinking 
Water Quality (GCDWQ) is established. The MAC derivation for benzene in drinking water is 
0.005 mg/L (5 μg/L) based on the NTP (1986) study. For cancer endpoint, the overall unit risk, 
given a lifetime exposure to benzene by ingestion of drinking water containing benzene at the 
MAC of 0.001 mg/L is reported as a range from 2.03 × 10-6 (based on malignant lymphoma in 
female mice) to 4.17 × 10-6 (based on bone marrow hematopoietic hyperplasia in male mice) 
(Health Canada, 2009). These unit risks assume a standard drinking water consumption rate of 3.5 
L-eq/day for humans. 
2.1.3 Benzene Kinetics and Metabolism  
Benzene is readily absorbed from oral and inhalation exposures, but from dermal exposure, 
absorption is very low due to rapid evaporation from skin (IRIS report, 2002). Distribution is rapid 
throughout the body following exposure by all routes of administration. Animals experimentally 
exposed to benzene orally at low concentrations have shown complete absorption. In Sabourin et 
al. (1987) studies following oral gavage (in corn oil) or intraperitoneal injection, the absorption of 
benzene from the GI tract in all animal subjects was found essentially to be 100 %. Supporting 
studies by Mathews et al. (1998) on laboratory animals treated by oral gavage showed that, at a 
high dose of benzene estimated at 100 mg/kg bw, a fraction of benzene was significantly 
eliminated by exhalation. It is suggested that the excretion routes might be influenced by benzene 
dose and a weight of evidence that suggest a linear increase in total metabolite production with 
exposure level. A greater proportion of benzene metabolites, at the low doses, are excreted in urine, 
and a shift to a greater proportion of unmetabolized benzene, at the high doses, excreted in exhaled 
air. Like absorption following oral ingestion, benzene (through inhalation) is better absorbed at 
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lower exposures versus higher exposures. Since extrapolation of animal studies data from exposure 
to oral doses to which humans are likely exposed suggest a dose-dependent linear increase in 
metabolite production, the dose-related production of metabolites in humans from benzene 
exposure is remained inadequately understood, more particularly at exposure to low levels of 
benzene. 
Benzene biotransformation results in the production of several metabolites in the liver, and 
interactions between these metabolites, are required for the expression of benzene toxicity (IRIS 
report 2002; Health Canada, 2009). Benzene is metabolized, primarily in the liver, by Cytochrome 
P450 2E1 (CYP2E1) (Health Canada, 2009; IRIS report, 2002; U.S. EPA, 1998; Snyder and Hedli, 
1996). Two metabolic pathways for biotransformation are commonly hypothesized as being 
responsible for benzene toxicity. The first pathway involves a variety of hydroxylases products, 
the major hepatic metabolites of benzene (phenol, catechol, and hydroquinone), and the second 
pathway involves ring-opened products of benzene (muconate derivatives) (Health Canada, 2009; 
IRIS report, 2002; U.S. EPA, 1998; Snyder and Hedli, 1996), an iron-catalyzed metabolism that 
forms trans, trans-muconaldehyde (MUC), a precursor of trans, trans-muconic acid (MA). The 
primary event in benzene metabolism is the hepatic conversion of benzene to epoxide, benzene 
oxide. Follow the formation of the epoxide; benzene oxide spontaneously rearranges 
(nonenzymatically) to form phenol, the major hydroxylated product of the first step in benzene 
metabolism. Phenol formation from benzene can occur via an alternative route through the 
hydroxylation of benzene by hydroxyl radicals generated from hydrogen peroxide (H2O2) (Snyder 
and Hedli, 1996). The CYP2E1, and perhaps other cytochrome P450, when function as oxidases 
of nicotinamide adenine dinucleotide phosphate (NADPH) can generate H2O2, through which the 
hydroxyl radical (•OH) is formed. Benzene oxide, alternatively, may react with glutathione (GSH) 
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catalyzed by glutathione S-transferase to form phenylmercapturic acid, a urinary metabolite that 
can be excreted via urine. Catechol formation occurs when benzene oxide undergoes enzymatic 
conversion to benzene dihydrodiol by epoxide hydrolase in the liver with subsequent conversion 
to catechol by dehydrogenase enzymes (Health Canada, 2009; IRIS report, 2002; U.S. EPA, 1998; 
Snyder and Hedli, 1996). Also, catechol can be formed by the oxidation of phenol. Further 
oxidation of phenol by mixed-function oxidases leads to the formation of hydroquinone. The p-
benzoquinone may be formed by the hydroxylation of hydroquinone catalyzed by peroxidases, 
essentially the myeloperoxidase (MPO) (Smith et al., 1989) that is reportedly present in bone 
marrow in high concentrations (Bainton et al., 1971). In bone marrow in vitro, bioactivation of 
hydroquinone by peroxidases to reactive quinone derivatives can result in covalent binding to 
protein (Subrahmanyam et al., 1989) and the formation of DNA adducts (Lévay et al., 1993). It 
has been postulated that interaction of phenolic metabolites may induce benzene toxicity or at least 
are a contributing factor to toxic effect. Phenol and hydroquinone interactions reproduce the 
myelotoxicity observed with benzene exposure (Eastmond et al., 1987). Catechol and 
hydroquinone interaction also have been observed to markedly promote a synergistic genotoxic 
effect in human lymphocytes (Robertson et al., 1991). 
2.1.4 Mechanism from Redox Cycling of Benzene Metabolites-induced Oxidative Stress 
 in the Bone Marrow 
After chronic exposure, benzene is metabolized by a hepatic enzyme (CYP2E1) to the 
intermediate metabolite, phenol (monohydroxylated benzene). Hydroquinone, once formed from 
oxidation of phenol, is further oxidized by myeloperoxidases to p-benzoquinone and then 
accumulates in the bone marrow. The p-benzoquinone has been directly linked to bone marrow 
toxicity, because it is a protein-reactive species that is highly reactive and can covalently bind to 
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cellular macromolecules (Snyder and Hedli, 1996; Boelsterli, 2003) or deplete cellular levels of 
GSH (Snyder and Hedli, 1996; Brunmark and Cadenas, 1988). The bone marrow is richly 
oxygenated and contains myeloperoxidase in high concentrations (Bainton et al., 1971), which is 
the biological basis of the bone marrow-selectivity of oxidant-induced stress and toxicity 
(Boelsterli, 2003). The myeloperoxidases catalyze the transfer of electron from easily oxidizable 
substrates such as phenol to generate reactive oxygen species (ROS) through the four-electron 
stepwise reduction of molecular oxygen (O2) that leads to the production of superoxide anion 
radical, hydrogen peroxide, and hydroxyl radical (Snyder and Hedli, 1996; Boelsterli, 2003). The 
oxidized benzene metabolite p-benzoquinone enzymatically undergoes reduction by CYP 
reductases of the mitochondria or endoplasmic reticulum via a one-electron transfer to yield the 
starting material (semiquinone anion radical) that may re-enter the redox cycle. Redox cycling 
between the benzene metabolites: semiquinone and quinone may generate superoxide anion 
radicals and oxidative stress in the bone marrow (Snyder and Hedli, 1996; Boelsterli, 2003). The 
ROS subsequently target macromolecules such as DNA and RNA, and exerts oxidative damage 
which may result in DNA strand breaks and chromosome damage (Boelsterli, 2003). Another 
metabolic pathway is the oxidative metabolism to the reactive trans-muconaldehyde, an open-ring 
microsomal metabolite of benzene. The toxicity of trans-muconaldehyde may stem from its 
interaction with key cells (macrophages and neutrophils) in the bone marrow, which may result in 
cell membrane damage, including loss of membrane integrity and alterations in membrane lipid 
fluidity (Witz et al., 1989).   
2.1.5 Mechanisms of Benzohydroquinone –glutathione-S-conjugate Nephrotoxicity 
Benzohydroquinone is a metabolite of benzene. Benzohydroquinone is a reactive electrophile 
that can covalently bind to nucleophilic sites of target organs. Benzohydroquinone is nephrotoxic 
14 
 
and may induce tumors by a mechanism involving cytotoxicity (Boelsterli, 2003). Following 
oxidation of benzohydroquinone to benzoquinone, the benzoquinone is conjugated to glutathione 
to form secondary metabolites (GS-conjugate isomers). The reactive GS-conjugate isomers are 
actively exported from the liver into bile. Intestinal reabsorption does occur after passing through 
the enterohepatic cyclic process, the GS-conjugates are released from the liver and transported to 
the systemic circulation. The GS-conjugate when delivered to the kidney, reaches the tubular 
lumen of the epithelial cells. Subsequently, the GS-conjugates are metabolically degraded by two 
peptidase enzymes that catalyse the removal of two amino acids off the GS complex leaving behind 
the cysteine conjugate and are taken up into the proximal tubular epithelia. The cysteine conjugate 
is bioactivated to the substituted benzoquinone by oxidation inside the tubular epithelial cells. The 
substituted benzoquinone (cysteine -S-conjugate of benzoquinone) retains the molecular 
characteristic of the parent compound (benzohydroquinone) and consequently exerts its 
nephrotoxic effects on the proximal tubular epithelium. The toxic effects may induce tumors or 
possible risk of cancer progression (nephrocarcinogenesis) in the tubular epithelia. 
2.1.6 CYP2E1 Gene Expression and Benzene Metabolism 
Cytochrome P450 2E1 (CYP2E1) gene expression and its ability to metabolically activate 
benzene may vary with inter-and intra-individual differences playing a significant role in human 
variability and the resultant differential risk from benzene exposure, since the enzyme is 
particularly involved in the metabolism of benzene (Hu et al., 1997; U.S. EPA, 1998). CYP2E1 
gene expression may be regulated at the transcription, translation, mRNA stabilization, and protein 
depletion levels (Danko and Chaschin, 2005; Ingelman-Sundberg et al., 1993). It has been 
demonstrated that there exists a correlation between CYP2E1 catalytic activity, mRNA level, and 
transcriptional activity of polymorphic gene variants (Danko and Chaschin, 2005). It is likely that 
15 
 
changes in CYP2E1 catalytic activity may be a consequence of gene induction or inhibition by 
exposure to potent environmental toxicants. Toluene is well known competitive inhibitor of 
benzene and has been consistently held to significantly alter the metabolism of benzene and certain 
other chemicals, contributing to a decrease in benzene metabolite production and resulting 
bioactivity of other chemicals, potentially influencing their toxicities (Andrews et al., 1977; Hsieh 
et al., 1990; and Fishbein 1985). Ethanol-inducible CYP2E1 has been shown to potentially play 
an important toxicological role in metabolism. Induction of CYP2E1 enzyme after ethanol 
treatment results in greater formation of reactive metabolites and may contribute to oxidative stress 
and increase toxicity and carcinogenic responses in the target organ (Hu et al., 1997). 
The physicochemical properties of toxicant, particularly lipophilicity (dissolved phase), and the 
dissolved species component of the toxicant also may largely influence the metabolism and 
bioavailability of the toxicant for a given animal or human, consequently determining the 
assimilation potential across barrier membranes before the reach of the target organ or systemic 
circulation. The present research aims to assess the physiologic parameters of the gastrointestinal 
tract such as dosage (bioavailable fraction), duration of exposure, and the transport-mediated 
mechanism (the integrity of cell monolayer by a measure of the transmembrane resistance) that 
drive the degree of uptake and transport of benzene through the gastrointestinal epithelium. 
2.2   In vitro Bioavailability/Bioaccessibility in Chemical Risk Assessment 
Two concepts of bioavailability (bioaccessibility and chemical activity) are fundamental in 
chemical risk assessment. A contaminant becomes accessible for biouptake when it is bioavailable. 
Hence, a look at bioavailability suggests two different divides: one that is readily available (termed 
bioavailable), and a portion of the total concentration that includes those molecules that can be 
mobilized and made available on desorption (termed bioaccessible) for diffusive uptake into an 
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organism (Reichenberg and Mayer, 2006). Chemical activity describes the energetic state of the 
test substance that determines the potential for spontaneous processes, such as diffusion, 
partitioning, and baseline toxicity (Reichenberg and Mayer, 2006; Niehus et al., 2018). Chemical 
activity is comparable to fugacity, which describes a “fleeing” or “escaping” tendency from a 
phase donor (McKay, 2001; Reichenberg and Mayer, 2006; Niehus et al., 2018) and it is also 
linearly related to freely dissolved concentrations (Table 2.5). The striking similarity of chemical 
activity to fugacity and freely dissolved concentration is mainly because all different parameters 
describe the energetic state of a chemical. Therefore, for an improved risk assessment of chemicals, 
bioavailability/bioaccessibility measurements can better characterize exposure estimates during in 
vitro bioassays. 
In bioassays, the risk assessors think of total aqueous concentrations of hydrophobic organic 
chemicals (HOCs) and, in theory, assume an absorption factor of 100% for exposure assessment 
(Richardson et al. 2006; Juhasz et al. (2014a). This assumption overestimates bioavailability, as it 
may exceed the freely dissolved concentration of test substance and, therefore, can potentially lead 
to overestimating the risk to target cells. Only the freely dissolved fraction solubilized into GI 
fluids or test medium can potentially be absorbed by the GI epithelium. 
 For volatile hydrophobic organic chemicals (VHOCs), the freely available fraction 
(bioaccessible portion) is often difficult to measure, can exhibit significant losses through sorption 
and volatilization, and can vary over time. This can result in poorly defined exposure of test 
substances and undermine the risk assessment and data interpretation. A passive dosing method 
can be applied to provide stable exposure concentrations of the biologically available fraction in 
aqueous tests to overcome these challenges. Passive dosing of contaminants is based on a uniform 
resupply of test substance into the test medium via passive diffusion from a biocompatible polymer 
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preloaded as partitioning donor (Smith et al., 2010). In the present research, a novel in vitro 
exposure technique driven by partitioning from a biologically inert polymer, silicone PDMS, was 
utilized to produce defined and stable exposure concentrations of a VHOC such as benzene in 
aqueous biotests. For the experiment, the passive dosing model is set up in transwell plates (Figure 
2.1). Then the silicone PDMS is preloaded with benzene and suspended in apical media via a 
plastic insert. Consequently, benzene is released into apical media by partitioning from a 
dominating polymeric phase, providing direct contact and constant exposure levels to the target 










Table 2.5     Comparing the parameters of bioavailability: Chemical activity (a), fugacity (f), and 
freely dissolved concentration (Cfree)      
 
Measure                                             Conversion a                                        Reference state                                                         
 
Fugacity                                             f ≈ P/PLsub                                                     Ideal gas            
 
Chemical activity                              a ≈ Cfree/SLsub                                                            Liquid compound            
                                                                         
 
 a Vapor pressure (P), subcooled liquid vapor pressure (PLsub), and Subcooled liquid solubility 






















The following data chapter will be submitted to the journal Environmental Science and 
Technology for publication. In the chapter, the primary focus is to develop and apply a new passive 
dosing approach for determining time-resolved freely dissolved fractions of the total benzene in 
aqueous tests for an improved assessment of benzene bioavailability to gastrointestinal cells during 
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3    DEVELOPMENT OF A DOSING SYSTEM TO ASSESS BENZENE BIOAVAILABILITY 
IN GASTROINTESTINAL CELLS  
3.1 Introduction  
Bioavailable fractions of VHOCs in aqueous tests are often difficult to assess with regards to 
risk assessment and toxicity testing with currently applied methods for introducing VHOCs into 
in vitro bioassays. In recent times, transition from in vivo to in vitro test methods has gained 
increasing acceptance in risk assessment of industrial chemicals and toxicological investigations 
(Barile, 1994; Gad et al., 2000; Bakand et al., 2005; Bakand et al., 2006; Anadón et al., 2014). 
With an extremely large number (> 86,000) of industrial chemicals in commerce (U.S. EPA, 2019), 
the potential application of in vivo test methods for toxicity studies of this large number can be 
technically more challenging and practically unachievable from the economic viewpoint (Bakand 
et al., 2005; Anadón et al., 2014). In vitro exposure techniques have demonstrated significant 
potential for rapidly providing toxicity assessment and risk evaluation of industrial chemicals and 
volatile test chemicals (Bakand et al., 2005; Bakand et al., 2006).  
Chemicals with characteristic high volatility (of air to water partition coefficients greater than 
one, i.e., K air, water >1) and highly hydrophobic (octanol to water partition coefficients above five, 
i.e., log Kow > 5) are generally difficult to test with currently available methods, such as direct 
solvent spiking and water accommodated fraction (Bakand et al., 2006; Trac et al., 2018; Trac et 
al., 2019; Hammershøj et al., 2020). As a result, toxicity testing and risk assessment of VHOCs 
face significant difficulties. In exposure assessment of chemicals in vitro, the ultimate goal is to 
estimate the biologically effective dose or assess optimal exposure concentrations and apply 
measures to minimize routine loss processes that otherwise would lead to a significant drop in 
exposure concentration during testing. Examples of such losses include compound losses to 
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headspace, sorption to the test vials or test vessels, walls of cell culture plates, and through 
volatilization, or degradation (Mayer et al., 1999; Riedl and Altenburger, 2007; Schreiber et al., 
2008; Smith et al., 2010), making it difficult to control exposure in in vitro tests. In typical dosing 
scenarios, losses up to 35 % were reported for VHOCs with a log Kow ˂ 4.6, such as naphthalene 
and acenaphthene (Niehus et al., 2018). Another challenge associated with volatiles or poorly 
soluble chemicals in in vitro experiments is encountered during efforts to ensure complete 
dissolution of the exposure concentrations in aqueous medium. Hydrophobic organic chemicals 
have very low aqueous solubilities (Mayer and Holmstrup, 2008). This physical-chemical 
characteristic limits their partitioning in the aqueous phase, thereby reducing the bioavailable 
concentration in aqueous test (Mayer et al., 1999; Mayer and Holmstrup, 2008). The bioavailability 
of a toxicant for a given animal or human is strongly dependent on the physicochemical substance 
properties, the exposure pattern, the duration, and frequency of the exposure. This phenomenon of 
reduced bioavailability compromises the quality of the risk assessment and estimation of the true 
exposure concentration of such chemicals (Mayer et al., 1999). 
Different experimental strategies have been pursued to improve the risk assessment of volatile 
hydrophobic chemicals. To prevent or minimize compound losses through volatilization, cultured 
cells are overlayed with a mineral oil layer to forcibly inhibit the vaporization of test substances 
from the culture medium (Yang et al., 2002; Bakand et al., 2006). Static methods have been used 
to generate the standard test atmospheres of volatile organic compounds through a glass chamber 
for direct air sampling and static exposure to cultured cells at the air/liquid interface (Bakand et 
al., 2006). Furthermore, octadecyl Empore disk and Silicone O-rings, and polydimethylsiloxane 
(PDMS) are used as polymer phase reservoir for hydrophobic organic chemicals (HOCs) for 
passive dosing of test substances (Mayer et al., 1999; Mayer and Holmstrup, 2008; Smith et al., 
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2010). The constant release of test substance into the test medium is then driven by continual 
partitioning from a dominating reservoir, following the principles of partitioning-driven 
administrations (Mayer et al., 1999; Brown et al., 2001; Mayer and Holmstrup, 2008; Kwon et al., 
2009; Smith et al., 2010). Many of these test strategies have mainly been applied to semi-volatile 
and hydrophobic organic chemicals (SVHOCs) (Bakand et al., 2006; Smith et al., 2010; Trac et 
al., 2019) or HOCs with moderate volatility (Stibany et al., 2017) in in vitro assays. However, there 
is a need to develop new in vitro exposure techniques and time efficient dosing methods suited for 
HOCs with high volatility, such as benzene.  
Benzene (log Kow, 2.13), a highly volatile hydrophobic, lipophilic, carcinogenic compound 
(Boelsterli, 2003; Van Noort, 2009), was selected for this study as an important chemical with 
extensive industrial applications and widespread contamination in groundwater and soils. Oral 
exposure to benzene occurs through incidental ingestion of contaminated groundwater or soil is an 
important route of human exposure.   
The basic in vitro cell culture techniques allow cells to be cultured primarily in flat-bottomed 
plates and then seeded in transwell or multi-well plates with permeable microporous membrane 
inserts. In the present study, we introduce a new passive dosing approach of highly volatile HOCs 
in aqueous tests for an improved risk assessment and toxicity testing during in vitro bioassays. A 
defining capability of this dosing model is the design for its compatibility. The passive dosing unit 
was designed to suit the physical dimension of transwell insert for cell culture plates, and the 
design is compatible with the standard multi-well plates, also practical and consistent with the 
operation of in vitro tests.  
To perform in vitro testing of volatile HOCs in toxicity assays, the key points of consideration 
are summarized as follows: the bioavailability of chemical agents to be assessed, exposure 
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modeling of chemical agents, and the cell lines used should closely mimic the phenotypic attributes 
of cells within the human or animal target tissues (Anadón et al., 2014). A chemical becomes 
accessible to humans or animal target if it is bioavailable and cross barrier membranes to enter the 
systemic circulation. However, currently available in vitro testing strategies are limited in their 
potential for assessing volatile contaminant bioavailability and toxicity to target cells from 
chemical exposure due to lack of standard methods for introducing VHOCs into in vitro bioassays 
(Hattemer-Frey et al., 1990; Trac et al., 2019). Therefore, the present study aims (i) to develop a 
dosing system to assess benzene bioavailability in gastrointestinal cells and (ii) to establish test 
systems that linked a well-characterized toxicological response to a well-defined exposure 
concentration of benzene in aqueous tests.  
3.2 Materials and Methods 
3.2.1 Chemicals and Materials 
Benzene (C6H6), CAS # 71-43-2, HPLC grade, ≥99.9%, was purchased from Sigma Aldrich 
Canada and served as a model chemical for this study. Silicone elastomer kit (MDX4-4210 kit) 
consisted of two components, a biomedical grade silicone polydimethylsiloxane (PDMS) and a 
cross-linking agent, was purchased from Krayden Inc., USA, and used for passive dosing in 
transwell plates. Silicone PDMS was chosen because it has been tested and proven a suitable 
biocompatible polymer material with excellent partitioning properties for hydrophobic organic 
chemicals (Mayer et al., 2000; Mayer and Holmstrup 2008; Smith et al., 2010). A standard 6-well 
cell culture-treated polystyrene microplates from Corning Life Sciences were used as supplied by 
the Fisher Scientific Canada. Also, all cell culture reagents consisted of Dulbecco modified eagle 
medium or DMEM/F-12, fetal bovine serum (FBS), N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid (HEPES), epidermal growth factor (EGF), insulin-transferrin/selenium (ITS), 
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penicillin, and streptomycin were obtained from Fisher Scientific Canada. Milli-Q ultrapure water 
(Milli-Q® Direct Water Purification System) was used. 
3.2.2 Preparation of the PDMS Mixture 
The silicone mixture was prepared first by mixing the PDMS prepolymer and the cross-linking 
agent in a 10:1 (w/w) ratio using ultra power hand mixer for 15 min. A 1-mL aliquot of 200 mg/L 
toluene solution was then added to the resulting mixture to facilitate the reduction of viscosity and 
was further mixed thoroughly for 15 min in a fume hood. This step also ensured the removal of air 
entrapped during mixing and enhanced more adsorption capacity (sorptive sites) of silicone PDMS 
for benzene. Subsequently, the mixture was poured into 15 mL conical sterile polypropylene 
centrifuge tubes, leaving the tubes to stand for at least 48 h at room temperature to allow the 
mixture to cure. After thermal curing at 100 °C in an oven for 8 h, the tubes were cooled at room 
temperature before the cured silicone (silicone bar) was removed from the tube. Silicone disks of 
1 g by weight were produced from the cured silicone using a sterile blade. Before use, silicone 
disks were cleaned to remove impurities. This was achieved by immersion in ethyl acetate for 24 
h.  
3.2.3 Adsorption Experiments 
3.2.3.1 Loading of the PDMS with benzene 
Silicone disks with a diameter of 17 mm were loaded by partitioning from methanol solution 
of benzene or a solution of benzene in water at 22 oC for 24 h. Loading was performed by adding 
1 g of the silicone disk to a 20 mL vial (Amber glass bottles) filled with 10 mL of adsorbate 
solutions at varied nominal concentrations. One mL of each nominal loading solution was 
transferred into a 10 mL headspace vial for headspace analysis by the gas chromatography-mass 
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spectrometry (GC-MS) to measure the initial concentration of adsorbate solutions before loading. 
The partitioning coefficient (KMeoH:PDMS) for the equilibrium benzene distribution between 
methanol and PDMS was determined using equation 1 below as described in Smith et al. (2010). 
The equilibrium partitioning ratio for benzene distribution between water and PDMS is expressed 
as Kwater:PDMS (eq 2). Concentrations of benzene in water and PDMS-sorbed benzene were from 
the loading experiments.  
                                                                             (1)                                                    
  
                                                                             (2)                                                    
 
 
3.2.3.2 Adsorption Equilibrium 
 Adsorption of benzene onto PDMS from aqueous solution was studied in a series of 10 mL 
adsorbate solutions of different initial concentrations ranging from 30 to 350 mg/L and a fixed 
adsorbent dosage of 1 g. The concentration range of benzene solutions used in this study was 
prepared by mixing a known amount of benzene standard with Milli-Q water to yield various 
concentrations of choice. The experiments were performed in 20 replicate batches. Each batch of 
the 20 replicate disks was loaded with benzene according to the procedure outlined in the previous 
paragraph. Control disks were loaded with ultrapure water only to the same dosing volume. The 
experiments were conducted under laboratory conditions with temperature control to 22 ± 0.52 oC. 
Each batch of experiment was repeated at least twice, yielding reproducible results under similar 
conditions at different times. The amount of benzene adsorbed onto PDMS was determined from 










the initial concentration of adsorbate solutions and equilibrium concentration using the equation 
below.  
Amount adsorbed (qe) = (C0 – Ce) * V/m                                                                (3) 
 
where qe denotes the amount adsorbed onto adsorbent in mg/g, C0 and Ce are the initial and 
equilibrium concentration (mg/L) of adsorbate solutions captured by the GC-MS respectively, V 
is the volume (L) of adsorbate solution and m is the mass (g) of the silicone PDMS. 
The Freundlich equation is used in this study to describe the correlation of the liquid-phase 
adsorption data (Hindarso et al., 2001; Ravi et al., 2018). This equation is presented in the 
following form.                 
𝑞𝑒 = 𝐾𝐹𝐶𝑒
1
𝑛⁄                                                                                                  (4) 
where qe is the equilibrium amount of benzene adsorbed to silicone in mg/g, Ce is the equilibrium 
concentration of benzene in water (mg/L), 𝐾𝐹 is the Freundlich adsorption constant (L/g), and 
1
𝑛⁄  
is the measure of intensity of adsorption. 
3.2.4 Desorption Experiments 
3.2.4.1 Initiating Exposure Concentrations in DMEM exposure medium 
 Freely dissolved fractions of benzene in the exposure medium were determined using passive 
dosing. The PDMS was loaded with benzene by adding 1 g of the silicone disk to a series of 20 
mL vials filled with 10 mL solution of benzene in water at nominal loadings of 30, 40, 80, 120, 
160, 240 mg/L for 24 h respectively. After loading, the silicone disks were rinsed with a small 
volume of DMEM medium. The loaded disks were then suspended in the apical medium via a 
plastic insert (see Figure 3.1) in six-well culture plates containing 6 mL apical medium (DMEM 
27 
 
only) and 4 mL of the same medium at the basolateral compartment. Benzene is released into the 
apical medium by partitioning from the stationary phase (PDMS), through direct contact with the 
aqueous medium, but with no direct contact between the PDMS donor and the target cell lines. 
The resulting release established a uniformly freely dissolved concentrations in the exposure 
medium. The equilibrium partitioning ratio for benzene distribution between PDMS and DMEM 
is expressed as KPDMS:DMEM and was calculated using the equation (eq 5). The concentration of 
benzene freely dissolved (Cfree) in the exposure medium was calculated using the equation as 
described (eq 6). The DMEM benzene concentration (mg L–1) was from the desorption equilibrium 
experiments at 37oC.  
                                                                          (5)                                                    
                                                                                                                                                                                                                                                                             
























Figure 3.1   Passive dosing system for assessing benzene bioavailability in gastrointestinal cells.  
 
                                                                                                                                                                                                                                            
3.2.4.2 Analytical Confirmation of Exposure Concentration 
 The released amount of benzene was determined from a 1 mL subsample of test medium taken 
at different times. Aliquot of 1 mL from each triplicate well was transferred into a 10 mL headspace 
GC injection vial containing a solution of methanol and Milli-Q water in a mixed ratio of 1:8 for 
analysis on a GC-MS equipped with a flame ionization detector (FID). All aqueous subsamples 
for headspace analysis were collected using a glass pipette. For quality control evaluation, a 
recovery spike of known benzene concentration (certified reference material) purchased from 
Sigma Aldrich Canada was added to the blank samples. The blank samples using Milli-Q water 
only were prepared following the same silicone loading and desorption equilibrium procedures. 
The percentage of recovery of the reference material was 90%, and the precision was 8% relative 
standard deviation for measured concentrations of the certified reference material. The GC-
MS/FID system was operated with a split 20:1 for the whole run. Samples for analysis were 
incubated for 5 min at 82°C and agitated before subsamples of 500 μL were drawn from the 
headspace vials. The injector temperature was 200°C with a constant column flow of 1 mL min-1. 
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The column employed was Bruker-BR86092 (30m × 0.25mm) with helium carrier gas at a flow 
rate of 27.5 mL min-1, air at a flow of 300 mL min-1, and hydrogen gas at a flow of 30 mL min-1. 
The oven temperature was program to initially 60°C, then increasing 15 °C min-1 to 150°C. 
3.2.5 Cell Viability and Cytotoxicity Tests 
3.2.5.1 Cell Culture 
 The intestinal porcine enterocyte cell line (IPEC-1 cells) was chosen for this test because it mimics 
the phenotypic attributes of cells within the humans more closely than other cells of non-human 
origin (Geens and Niewold, 2011). The IPEC-1 cell is of swine small intestinal (jejunum/ileum) 
origin. However, IPEC-1 cell as a model for the human intestine has been widely used as an in 
vitro model of the small intestine for assessing the intestinal permeability and cellular response of 
orally ingested chemicals of natural or synthetic origin (Gonzalez-Vallina et al., 1996; Diesing et 
al., 2011). The IPEC-1 cell, when grown in culture, differentiates to exhibit a densely microvilli-
like appearance on their apical surface characteristic of the small intestine enterocytes. For IPEC-
1 cell culture, the cells were cultured in transwell membrane insert for passive dosing tests to assess 
benzene bioavailability and toxicity to gastrointestinal cell lines. IPEC-1 cells kindly donated by 
Dr. Natacha Hogan, Department of Animal and Poultry Science, University of Saskatchewan, 
Canada, at passage 44 were cultured in DMEM/F-12 (1:1). The culture medium was supplemented 
with 25 mL FBS (10 %, v/v), 5 mL HEPES, 100 μL EGF, 5 mL ITS, and 5 mL 
penicillin/streptomycin. The cell cultures were maintained in 75 cm2 cell culture flasks at 37 °C in 
an incubator containing humidified air (95 %) and CO2 (5 %). The culture medium was changed 
every three days. At 80-90 % confluence (day 4–5 of culture), cells were harvested from the flask 
by a trypsin wash with 5 ml solution of trypsin (0.5 mg/L) containing 0.22 g/L ethylenediamine 
tetra-acetic acid or EDTA. For propagation, cells were seeded at a density of 1.4 × 105 cells/3 mL 
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culture media into the apical chamber of the transwell membrane insert, and 4 ml culture media 
only to the basolateral compartment. The culture medium was routinely changed every three days, 
beginning the second day post-seeding. The transepithelial electrical resistance (TEER), expressed 
in ohm cm2 (Ω cm2), was measured using a Millicell STX probe until stable TEER values were 
reached after 12 d. After a total culture period of approximately 14 days, cells were exposed to 
benzene by passive dosing for cytotoxicity tests.  
3.2.5.2 In Vitro Bioassays 
  Assays for determining cell viability and cytotoxicity were performed by employing cell 
proliferation reagent WST-1 (tetrazolium salts). The WST-1 cytotoxicity assay is based on the 
measurement of colorimetric differences that appear when cells start to die after exposure to in 
vitro treatments. For this assay, a new passive dosing approach for controlling benzene in vitro 
exposure regime was applied to determine the effective concentration and toxicity of benzene to 
IPEC-1 cells. Nominal concentrations of benzene were prepared by mixing benzene standards with 
ultrapure water to produce varied desired concentrations. Silicone disks were dosed in three 
replicate batches at nominal loadings of 40, 80, 120, 130, 140, 150, and 160 mg/L of benzene. 
Blanks were also prepared in three replicates, which were loaded with ultrapure water only in the 
same loading step. Before the cell viability test, cells were cultured in a transwell insert. Each 
treatment group consists of three replicate wells. At test start, media was aspirated off and to each 
well, 6 mL media (DMEM only) was added to the apical side of the cell insert and 4 ml of the 
same media to the basolateral compartment in a 6-well plate. We used DMEM medium only in the 
passive dosing tests (24 h exposure) to ensure the determination of the true exposure concentration 
freely available to cells. Sorption of the test compound to the medium constituents has been 
reported in previous studies. When sorption occurs, it can lead to altered release kinetics and an 
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enhanced diffusive transport into the culture medium (Smith et al., 2010). The dosed silicone disks 
were removed from the loading solutions and rinsed with a small volume of Milli-Q water to 
remove any solvent residues. The silicone disk was then transferred into the apical insert and 
remained suspended in the apical medium via a plastic insert. The toxicity of benzene on the 
viability of IPEC-1 cells was determined after 24 h of passive dosing at 37 °C in an incubator 
containing humidified air (95 %) and CO2 (5 %).  
After 24 h incubation, media (experimental treatments) were aspirated, and to each replicate 
well, 1 mL media (DMEM, supplemented with FBS, HEPES, EGF, ITS, and 
penicillin/streptomycin) containing 10% WST-1 reagent was added to the apical side of the cell 
insert. The culture plate was incubated for an additional 3 h and measurement of absorbance of the 
treatment samples against a background control as blank were taken at 0.5, 1, 2, and 3 h using a 
multi-well spectrophotometer plate reader (ELISA reader) at 440 nm and a background reference 
wavelength at 620 nm. Viable, metabolically active cells produce cellular reductase enzymes, 
NADPH. The presence of NADPH facilitates the intracellular conversion of the WST-1 
tetrazolium salts cleavage to formazan dye (Berridge et al., 1996). The number of viable cells 
directly correlates with the absorbance of formazan dye, which was measured to quantify the 
degree of cytotoxicity that occur in cells resulting from in vitro treatments. The calculated mean 
% cell viability of the media control samples was used as the reference for estimating the cell 
inhibition resulting from benzene toxicity in the treatment groups. A dose-effect relationship 
between the freely dissolved concentration of benzene in the exposure medium and partitioning of 
benzene into the cell membranes was generated by plotting the measured equilibrium 
concentration of benzene freely available to cells (CDMEM) as a function of cell viability. The 
32 
 
toxicity of benzene was also linked to calculated chemical activity (a) of benzene concentration 
exerting the observed effects:                            
                                                                         (7)                                                    
where SLsub is the subcooled liquid solubility. The value for SLsub of benzene, 1.36 mmol/L (106.22 
mg/L) was obtained from Van Noort, (2009).  
In separate experiments, we estimated the viability of IPEC-1 cells from a direct spiking of 
benzene in aqueous tests using a glass syringe, for comparison between the two dosing methods 
(spiking and passive dosing). On both tests, the median effective concentration of passive dosing 
(ECPDMS-50) and spiking (ECSpike-50) applications in the cell viability tests were evaluated from 
the dose-response relationship. The median effective activity (Ea50) value was calculated as a 
measure of the baseline toxic potential of benzene for IPEC-1 cells using the equation (eq 8).                              
                                                                            (8)                                                    
 
3.2.6 Statistical Analysis 
Benzene adsorption to silicone between partitioning from a methanol suspension of benzene 
and a mixed benzene solution in water was compared by one-way analysis of variance (ANOVA) 
with the software OriginPro (2020b) to determine the preferential adsorption of benzene that 
differs significantly from the two loading solutions. A post hoc test was performed using the 
Bonferroni test to compare the mean difference of equilibrium benzene distribution between each 
aqueous partitioning phase and silicone. The Levene test was used to verify the homogeneity of 
variance assumption. The median effective concentration from passive dosing (ECPDMS-50) and 
direct spiking (ECSpike-50) applications in the cell viability tests was estimated by R software 
Chemical activity (a)











package. All adsorption equilibrium modelling was carried out in SigmaPlot, Ver 14.0. Data from 
a dose-response relationship for the effect of benzene on the viability of IPEC-1 cell line after 
exposure to benzene were fitted by SigmaPlot using global curve fitting.  
 
3.3 Results  
3.3.1 PDMS Loading 
 Partitioning of benzene from water to PDMS was higher than from a methanol loading solution 
(one-way ANOVA, F = 31.713, p = 0.001), (Figure 3.2). The amount of actual loadings of benzene 
ranged from 80 to 88% of the nominal loading from a solution of benzene in water and were 
between 47 and 66% of the nominal loading from a methanol solution following loading of silicone 
disks for 24 h with benzene. The standard deviations ranged from 2.5 to 5.8% for calculated 
recoveries of the loading. For the passive dosing experiments, the silicone disks were loaded by 
partitioning from a water suspension of the respective benzene concentrations for 24 h. The amount 
of benzene adsorbed to PDMS increased with increasing solution concentration (up to 160 mg/L 
nominal concentration) of benzene (Table 3.1) and time. The results obtained from the adsorption 
experiments indicate that the adsorption equilibrium of benzene was reached about 98 min, and 
the sorption rate constant (𝑘) (min-1) was less than 1 min (Figure 3.3A and B). Chemical 
partitioning varied with concentration. At low concentration, benzene equilibrium distribution 
between liquid and solid phase silicone PDMS demonstrates excellent partitioning of benzene for 
silicone, partitioning pattern showed small deviations both at medium and high concentration, as 
shown in Figure 3.4. The best explanation for this deviation is that benzene partitioning to silicone 
were possible until a certain concentration, above which the concentrations in the silicone reach 
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Figure 3.2   Loading of the silicone disks with benzene from a solution of benzene in water and 
methanol at a concentration range of 5 to 100 mg/L (error bars represent standard deviations of 
four replicates). At the 0.05 level, benzene adsorption to silicone is significantly different 
between the aqueous partitioning phases (one-way ANOVA, p = 0.001, followed by a post hoc 










Figure 3.3   (a) Contact time on adsorption of benzene to silicone PDMS. Conditions: 1 g of 
silicone PDMS, 10 mL of mixed benzene solution (in water) at an initial nominal concentration 
of 30 mg L-1 and a temperature of 22 °C. (b) The sorption rate constant (𝑘) of benzene to silicone 
PDMS. 𝑞𝑒 = Equilibrium amount of benzene adsorbed (mg g
-1); 𝑞𝑡 = Amount of benzene (mg g
-
1) adsorbed to the silicone PDMS at time 𝑡; 𝑡𝑒= Time for adsorption to reach equilibrium (min); 





Figure 3.4   Freundlich adsorption isotherm for the adsorption behavior of benzene to silicone 
PDMS. 𝑞𝑒 = Equilibrium amount of benzene adsorbed (mg g
-1), 𝐶𝑒= Equilibrium concentration 
of benzene in water (mg L-1), 𝐾𝐹 = Freundlich adsorption constant (L g
-1), 1 𝑛⁄  = Measure of 




3.3.2 Initiating Freely Dissolved Concentrations 
 Freely dissolved concentration of benzene in the exposure medium was established within 30 
minutes of passive dosing and maintained throughout a normal exposure period of IPEC-1 cells 
(Figure 3.5). A linear relationship between the desorbed concentration of benzene freely available 
to cells in the culture medium and nominal concentration adsorbed by the silicone after 90 min is 
provided in the appendix (Figure A1). The DMEM concentrations of benzene remained stable for 
24 h. The buffering capacity of the dosed silicone disk freely compensates for routine losses that 
otherwise would lead to a decreasing benzene concentration. The measured concentrations of the 
free fraction of benzene in the exposure medium (Cfree), with their calculated chemical activity (a), 









Figure 3.5   Release of benzene into cell culture medium by passive dosing plotted against time. 
Error bars represent standard deviations of four replicates, and non-visible error bars are smaller 
than symbols.
Time (min)











































Table 3.1   Benzene loading concentrations, octanol-water coefficient (log Kow) and (subcooled) liquid solubility (SLsub). Also shown 
are equilibrium concentrations of benzene in the silicone PDMS (CPDMS), equilibrium partitioning ratios for Water:PDMS (Kwater:PDMS, 
L L –1), PDMS:DMEM (KPDMS:DMEM, L L 
–1) at 37 °C, freely dissolved concentrations (Cfree) measured in DMEM medium at test 
termination as well as the calculated chemical activity (a).         
 
                                                           Log Kow                          SLsub (mmol/L)    
 
                                                             2.13                                     1.36 a  
 
      Nominal loading mg/L    Cinitial (measured) mg/L*   CPDMS mg/L* b
   
 Cfree (measured) mg/L* 
   
Kwater: PDMS   KPDMS: DMEM    (a)      
                                                                        
          40          20.65 ± 0.42          18.24 ± 0.27         0.6 ± 0.01                   1.13        30.41        0.01 
          80          35.16 ± 0.44          30.32 ± 0.83         1.7 ± 0.07                   1.16        17.84        0.02 
              120         60.17 ± 1.84          54.46 ± 1.79         3.2 ± 0.95            1.10        17.02        0.03 
              130          60.77 ± 1.79          54.93 ± 1.73         3.4 ± 0.51                   1.11        16.15        0.03 
          140          61.52 ± 2.78          54.85 ± 2.61         4.2 ± 0.68                   1.12        13.06        0.04 
              150         70.47 ± 1.60          62.07 ± 1.24         4.8 ± 0.74            1.14        12.93        0.05 
              160         75.94 ± 1.77          67.22 ± 1.57         5.4 ± 1.04                   1.13        12.45        0.05 
 
 a Taken from Van Noort, (2009) at 25 oC but converted to 106.22 mg L–1 for calculation purposes. 
 b Based on equation (eq. 2).  










3.3.3 Cytotoxicity Test  
 With the silicone model, there is more than 90% cell inhibition, resulting in an ECPDMS-50 of 
4.82 mg/L (Figure 3.6A). Without silicone, we did not see any response at all, resulting in an 
ECSpike-50 projected to be greater than 5.4 mg/L, (highest spiked concentration), and reduced test 
sensitivity of benzene to IPEC-1 cells. This highlights the significance of passive dosing in risk 
assessment and toxicity testing of VHOCs. The effective chemical activity causing 50% toxicity 
(Ea50) was calculated to be 0.0454 (0.048 mg/L, predicted value), which reflects the sensitivity of 
IPEC-1 cells to benzene (Figure 3.6B). The median effective activity (Ea50) was determined as the 
ratio between the calculated ECPDMS-50 value and the SLsub of benzene. The Ea50 value for IPEC-
1 cells from the present study is within the chemical activity range (0.01– 0.1) for baseline toxicity 













Figure 3.6  A dose-response relationship for the effect of benzene on the viability (%) of IPEC-1 
cell lines after exposure to benzene (0.6, 1.7, 3.2, 3.4, 4.2, 4.8, 5.0, and 5.4 mg/L) for 24 h via the 
passive dosing silicone model approach. Cell inhibition ranged from 9.6 ± 2% to 97.7 ± 0.8%. 
The total number of replicates = 6, from two experiments conducted in three replicate batches 
under similar conditions at different times, and the repeats were taken as replicates. The dose-
response was significant (p < 0.001).  
 
3.4 Discussion  
This study introduces a unique passive dosing architecture compatible with the standard 6-well 
transwell plates for excellent passive dosing performance in vitro tests. Passive dosing techniques 
establish and control the partitioning of single compounds and simple mixtures between different 
phases (Mayer et al., 1999; Mayer and Holmstrup, 2008; Brown et al., 2001; Smith et al., 2010a; 
Stibany et al., 2017; Trac et al., 2018; Trac et al., 2019; Smith et al., 2010). More recently, the use 
of passive dosing has been explored in exposure control of complex mixtures of hydrocarbons in 
aquatic tests (Redman et al., 2017; Bera et al., 2018; Hammershøj et al., 2020). However, no system 
has yet been developed for VHOCs. For in vitro testing of VHOCs, passive dosing application has 
several advantages: (1) true exposure concentration in the test medium can be established, (2) a 
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resupply of test substance through phase partitioning from a dominating polymer phase donor can 
be achieved to compensate for compound losses during the test, (3) controls in vitro exposure 
concentrations at a relatively constant chemical activity, (4) offers the possibility of estimating the 
actual dose or biologically effective dose at the target site, and (5) the chemical potential that drives 
the equilibrium partitioning of the test chemicals into the cell membranes is determined by the 
chemical concentration in the partitioning donor and can be quantified by its chemical activity. 
Benzene at high exposure levels can act as a narcotic (Bingham et al., 2001), and nonpolar 
narcotic chemicals such as highly hydrophobic organic substances are known to exert baseline 
toxicity in aquatic organisms (Mayer and Reichenberg, 2006b; Schmidt and Mayer, 2015; Trac et 
al., 2019). Baseline toxicity or nonpolar narcosis describes the minimal effect exerted at the site of 
toxic action in membranes by partitioning of nonpolar (lipophilic) chemicals into the lipid bilayer 
of cell membranes at a relatively constant exposure concentration (Van Wezel and Opperhuizen, 
1995; Reichenberg and Mayer, 2006; Mayer and Reichenberg, 2006b). Based on our study, the 
obtained value for the ECPDMS-50/ SLsub ratio, an indicator of the baseline toxic potential of benzene 
for IPEC-1 cells, is within the chemical activity range (0.01– 0.1) for baseline toxicity of several 
non-polar narcotic chemicals, such as Toluene, Xylenes, and Benzophenone reported in previous 
study (Schmidt and Mayer, 2015). Comparison to other previously published studies also suggests 
that the ECPDMS-50 from the present study is lower than the EC50 values reported in the range of 
4.97 – 5.55 mg/L for IEC-6 cells (rat intestinal epithelial cell line) (Upreti et al., 2007), following 
experimental exposure to arsenic. In real-world exposure scenarios, risk assessors commonly adopt 
a conservative estimate that assumes an absorption factor of 100% for exposure assessment. But, 
gastrointestinal absorption of orally ingested hydrocarbons is known to vary based on the type of 
hydrocarbons (the physiochemical substance properties). The test system developed in this study 
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produced a more realistic estimate of the effective concentration of benzene that is present in a 
biologically available form by measuring the amount of benzene molecules that became available 
on desorption and solubilized into simulated GI fluids (DMEM). In exposure assessment of 
chemicals normally conducted in vitro, high hydrophobicity and volatility of chemicals may result 
in a series of pulses of high concentrations or poorly defined exposure concentrations. This study 
produced a suitable passive dosing method for in vitro tests in multi-well plates and demonstrated 
excellent passive dosing efficiency over solvent spiking, thus improving the predictive power of 
toxicity data from the in vitro tests.  
For risk assessment of human exposure to benzene at contaminated sites, in vivo models will 
best simulate the exposure conditions and bioavailability. However, due to ethical considerations 
in the use of animal models in toxicity tests, the development of new in vitro models simulates the 
exposure conditions as in vivo and ensure reliable results can be extrapolated to the population of 
interest, including humans. Essentially, for benzene to be accessible to humans, it must be 
bioavailable and cross barrier membranes to exert toxic effects at target sites. In the present study, 
we developed and applied a new passive dosing approach for assessing the bioavailable 
concentrations of benzene in aqueous tests. From a risk assessment level, acute toxicity of benzene 
was assessed by estimation of the EC50 using the toxicity test data from the cell viability assay. 
Correlating the effective concentration exerting the observed cell inhibition of 97% at maximum 
chemical activity thus suggests that benzene has acute toxicity towards IPEC-1 cells at the 
maximum aqueous exposure level (Bingham et al., 2001).  
Further in risk assessment of benzene, the potential risk commonly associated with benzene 
exposure was demonstrated in a previous study by Martinez-Velazquez et al. (2006), using the 
cultured hepatic cell line HepG2. Martinez-Velazquez et al. (2006) have reported that benzene 
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exposure to cultured cells induced oxidative stress, cell cycle alterations, and a higher decrease in 
cell viability was found. The low viability was reportedly due to apoptosis - a mechanism 
commonly known as programmed cell death in cultured cells exposed to such toxicants as benzene. 
To assess benzene risk to humans from oral exposure, using in vitro cell models to predict benzene 
metabolism in humans may have important implications for risk assessment. In risk assessment of 
benzene oral ingestion, the gut microbiota may play a critical role in metabolism. Mounting 
evidence has shown that bacteria-dependent metabolism of chemicals influences the in vitro 
bioaccessibility and absorptive properties of the gut wall (Laird et al., 2007; Laird et al., 2013) and 
modulates the toxicity for the host (Claus et al., 2016). It has been postulated that the human health 
risk assessment that eliminates the inclusion of microbial activity may underestimate in vitro 
bioaccessibility of ingested chemicals (Laird et al., 2013). It highlights the importance of gut 
microbes to biotransform environmental chemicals, influencing their partitioning across the 











4    SYNTHESIS, CONCLUSIONS, LIMITATIONS AND FUTURE DIRECTIONS 
4.1 Synthesis and conclusions  
The bioavailability of contaminant for a given animal or human is largely dependent on the 
physicochemical substance properties, the exposure route along which the chemical is absorbed 
by the body, the exposure pattern, the duration, and frequency of the exposure. A primary concern 
is human health risk assessment for the oral absorption through incidental ingestion of VHOCs 
like benzene at downstream hydrocarbon sites, either from groundwater or from adhered soil. 
However, it is ethically difficult to justify animal use to estimate oral bioavailability at a 
contaminated site. Apart from ethical complications, animal models are costly and time 
consuming. Consequently, in-vitro test system is increasingly recognized as alternative to animal 
model. Currently, a major challenge in in vitro testing of VHOCs is the commonly observed 
decrease in bioavailable concentration in aqueous tests as a result of (bio) sorption, volatilization, 
or degradation, and more challenging to control chemical activity during the test. This 
compromises the quality of the risk assessment of such test chemicals. Hence, the goal of this 
research was to develop a partition-controlled delivery model via passive dosing to enable a well-
defined exposure for an improved risk assessment of VHOCs during in vitro bioassays. Chapter 3 
reported a novel finding on how passive dosing was utilized for determining time-resolved freely 
dissolved fractions of the total benzene in aqueous tests. This chapter concludes that in aqueous 
tests, the utility of passive dosing to control in vitro exposure of benzene produces a defined 
exposure level, resulting in a well-characterized toxicological response in gastrointestinal 
epithelial cells. The dosing approach used in chapter 3 was novel because it provides a direct and 
quantitative determination of the freely available concentration of benzene to cells at its maximum 
chemical activity, thus improving the predictive power of toxicity data from the in vitro tests. This 
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passive dosing approach is promising and could be applied to future toxicity testing of VHOC in 
complex mixtures.  
4.2 Limitations  
In the present study, the passive dosing method produced the best in vitro assessment of benzene 
bioavailability in aqueous tests and demonstrated significant potential for improving the risk 
assessment of benzene. Though, in vivo animal bioavailability models, such as rat or swine, are 
the best standard for assessing contaminant bioavailability across the gastrointestinal epithelium. 
The lack of gut bacterial in in vitro cell exposure posed a limitation to in vitro models predicting 
in vivo bioavailability. The gastrointestinal (GI) microbiota is increasingly recognized for its 
importance in the metabolism of orally ingested chemicals and a variety of gastrointestinal 
functions (such as intestinal absorption) of the host (Blaut and Clavel, 2007). As a consequence, 
the absence of gut microbiota in in vitro cell models to mimic in vivo models may be a critical 
limitation to estimating benzene bioavailability to IPEC-1 cells.   
4.3 Future Directions  
In aquatic environments, the quantitative assessment of potential risk from benzene exposure 
in complex mixtures is significant, given that benzene contaminations frequently occur as a joint 
mixture with chemicals of potential environmental concerns. Future research may be directed 
toward investigating the potential risk of benzene from interactions with environmental 
contaminants. 
For future research direction, further study on interactions of VHOCs with potent toxicants such 
as heavy metals, for instance, arsenic that is commonly found in contaminated soil and 
groundwater, is required to investigate how metals interact with benzene to influence toxicity 
responses in IPEC cells. The most toxicological concern of arsenic is its carcinogenic potential, as 
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the case for benzene. Studies of the interaction between arsenical and other elements have 
suggested that one can ultimately alter the metabolism or toxicity of the other (Kraus & Ganther, 
1989). However, the interactive effects of arsenic on benzene metabolism and transport in 
epithelial cells remain unknown. Crucial to the future study is how arsenic and other environmental 
carcinogens may influence benzene transport process in the intestinal epithelial cells. This has 
fundamental implications for understanding the interaction between VHOCs, metals, and the 
human intestinal cells to help set remediation objectives in future risk assessment. 
Further, the silicone dosing format developed in this study was applied to improving in vitro 
toxicity testing of single VHOC exposure. The silicone passive dosing in vitro test system can also 
play a vital role in the risk assessment of VHOC mixtures, such as benzene in a joint mixture with 
Toluene, Ethylbenzene and Xylenes (BTEX). Hence, the baseline toxicity of the chemical mixtures 
will generally assume concentration additivity. Also, the estimation of true exposure concentration 
of each mixture constituent can be highly compound-specific, depending on the compound being 
a HOC with moderate or high volatility (Riedl et al., 2007, Schreiber et al., 2008; Smith et al., 
2010). With benzene being a highly VHOC, the passive dosing system developed in this study 
demonstrated excellent passive dosing performance for benzene. It will also be best suited for 
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CHAPTER 3 SUPPLEMENTAL INFORMATION 
 
The following figure presents a linear regression model for deriving equilibrium benzene 
concentrations (𝐶𝑒) of nominal in cell culture medium (DMEM) after equilibration with the 
silicone PDMS. The simple linear regression statistically relates 𝐶𝑒 to nominal through an equation 
of the form 𝐶𝑒= -8.332 + 5.699 ˣ logCnominal. This equation can be used as a predictive model for 
calculations of exposure concentrations to enhance estimations of benzene bioavailability based 





































Figure A1   A linear regression model of the relationship between the desorbed concentration in 
DMEM and nominal concentration adsorbed by the silicone PDMS after 90 min. 𝐶𝑒= 
Equilibrium concentration of benzene in water (mg L-1); r2Adj = Adjusted coefficient of 
determination. 
 
